These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 25230372)
1. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. Sun Y; Hu L; Zheng H; Bagnoli M; Guo Y; Rupaimoole R; Rodriguez-Aguayo C; Lopez-Berestein G; Ji P; Chen K; Sood AK; Mezzanzanica D; Liu J; Sun B; Zhang W J Pathol; 2015 Jan; 235(1):25-36. PubMed ID: 25230372 [TBL] [Abstract][Full Text] [Related]
2. Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10. Fan L; Lei H; Zhang S; Peng Y; Fu C; Shu G; Yin G Theranostics; 2020; 10(13):5895-5913. PubMed ID: 32483426 [No Abstract] [Full Text] [Related]
3. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer. Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein. Ying X; Wei K; Lin Z; Cui Y; Ding J; Chen Y; Xu B Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer. Cao Y; Shi H; Ren F; Jia Y; Zhang R Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469 [TBL] [Abstract][Full Text] [Related]
6. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499 [TBL] [Abstract][Full Text] [Related]
7. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Yang D; Sun Y; Hu L; Zheng H; Ji P; Pecot CV; Zhao Y; Reynolds S; Cheng H; Rupaimoole R; Cogdell D; Nykter M; Broaddus R; Rodriguez-Aguayo C; Lopez-Berestein G; Liu J; Shmulevich I; Sood AK; Chen K; Zhang W Cancer Cell; 2013 Feb; 23(2):186-99. PubMed ID: 23410973 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer. Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687 [TBL] [Abstract][Full Text] [Related]
9. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4. Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1. Jin M; Yang Z; Ye W; Xu H; Hua X PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005 [TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Zhang Y; Dun Y; Zhou S; Huang XH Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819 [TBL] [Abstract][Full Text] [Related]
12. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway. Guo QY; Song JN; Chen YM; Yuan HN; Xue WS; Sun Y; Niu XL; Wang Y; Chen X Med Oncol; 2024 May; 41(6):155. PubMed ID: 38744773 [TBL] [Abstract][Full Text] [Related]
13. Effects of miR-9-5p on the migration, invasion and epithelial-mesenchymal transition process in cervical squamous cell carcinoma. Kuang T; Li L; Chen Y; Wang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):15-23. PubMed ID: 36935173 [TBL] [Abstract][Full Text] [Related]
14. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. Guo F; Cogdell D; Hu L; Yang D; Sood AK; Xue F; Zhang W Oncol Rep; 2014 May; 31(5):2021-8. PubMed ID: 24677166 [TBL] [Abstract][Full Text] [Related]
15. microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition. Wang SH; Li X; Zhou LS; Cao ZW; Shi C; Zhou CZ; Wen YG; Shen Y; Li JK Tumour Biol; 2013 Dec; 34(6):3705-12. PubMed ID: 23873106 [TBL] [Abstract][Full Text] [Related]
16. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer. Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672 [TBL] [Abstract][Full Text] [Related]
17. miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells. Ye Z; Zhao L; Li J; Chen W; Li X Int J Gynecol Cancer; 2015 Nov; 25(9):1574-81. PubMed ID: 26501435 [TBL] [Abstract][Full Text] [Related]
18. MiR-506: A Multitasker in Suppression of the Epithelial-to-Mesenchymal Transition. Sun Y; Mezzanzanica D; Zhang W RNA Dis; 2014; 1(1):e447. PubMed ID: 26029740 [TBL] [Abstract][Full Text] [Related]
19. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway. Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697 [TBL] [Abstract][Full Text] [Related]
20. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Parikh A; Lee C; Joseph P; Marchini S; Baccarini A; Kolev V; Romualdi C; Fruscio R; Shah H; Wang F; Mullokandov G; Fishman D; D'Incalci M; Rahaman J; Kalir T; Redline RW; Brown BD; Narla G; DiFeo A Nat Commun; 2014; 5():2977. PubMed ID: 24394555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]